Cancer: New Needs, New Models. Is It Time for a Community Oncologist? Another Brick in the Wall

Por Tralongo, Paolo, Gebbia, Vittorio, Mercadante, Sebastiano, Bordonaro, Roberto, Ferraù, Francesco, Barni, Sandro, Firenze, Alberto
Publicado no Cancers (Basel) (2021)

Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in pati...

Por Del Re, Marzia, Michelucci, Angela, Di Leo, Angelo, Cantore, Maurizio, Bordonaro, Roberto, Simi, Paolo, Danesi, Romano
Publicado no EPMA J (2015)

Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns()

Por Gebbia, Vittorio, Bordonaro, Roberto, Blasi, Livio, Piazza, Dario, Pellegrino, Alessandro, Iacono, Carmelo, Spada, Massimiliano, Tralongo, Paolo, Firenze, Alberto
Publicado no J Cancer Policy (2020)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

Por Lazzaro, Carlo, Bordonaro, Roberto, Cognetti, Francesco, Fabi, Alessandra, De Placido, Sabino, Arpino, Grazia, Marchetti, Paolo, Botticelli, Andrea, Pronzato, Paolo, Martelli, Elisa
Publicado em 2013

Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19 (Review)

Por Vivarelli, Silvia, Falzone, Luca, Torino, Francesco, Scandurra, Giuseppa, Russo, Giulia, Bordonaro, Roberto, Pappalardo, Francesco, Spandidos, Demetrios A., Raciti, Giuseppina, Libra, Massimo
Publicado no Int J Oncol (2020)

Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials

Por Rosati, Gerardo, Cordio, Stefano, Reggiardo, Giorgio, Aprile, Giuseppe, Butera, Alfredo, Avallone, Antonio, Tucci, Aniello, Novello, Giuseppe, Blanco, Giuseppina, Caputo, Giuseppe, Bilancia, Domenico, Bordonaro, Roberto
Publicado no Cancers (Basel) (2019)

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC...

Por Damato, Angela, Iachetta, Francesco, Antonuzzo, Lorenzo, Nasti, Guglielmo, Bergamo, Francesca, Bordonaro, Roberto, Maiello, Evaristo, Zaniboni, Alberto, Tonini, Giuseppe, Romagnani, Alessandra, Berselli, Annalisa, Normanno, Nicola, Pinto, Carmine
Publicado no BMC Cancer (2020)

Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study

Por Clavarezza, Matteo, Bordonaro, Roberto, Daniele, Bruno, Ferrandina, Gabriella, Barni, Sandro, Turazza, Monica, Coati, Francesca, De Matteis, Andrea, De Placido, Sabino, Cognetti, Francesco, Olmeo, Nina Antonina, Carrozza, Francesco, Bruzzi, Paolo, Del Mastrol, Lucia
Publicado em 2013

Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study

Por Clavarezza, Matteo, Bordonaro, Roberto, Daniele, Bruno, Ferrandina, Gabriella, Barni, Sandro, Turazza, Monica, Coati, Francesca, De Matteis, Andrea, De Placido, Sabino, Cognetti, Francesco, Olmeo, Nina Antonina, Carrozza, Francesco, Bruzzi, Paolo, Del Mastro, Lucia
Publicado em 2013

HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives

Por Fanotto, Valentina, Ongaro, Elena, Rihawi, Karim, Avallone, Antonio, Silvestris, Nicola, Fornaro, Lorenzo, Vasile, Enrico, Antonuzzo, Lorenzo, Leone, Francesco, Rosati, Gerardo, Giuliani, Francesco, Bordonaro, Roberto, Scartozzi, Mario, Maglio, Giovanna De, Negri, Francesca V., Fasola, Gianpiero, Aprile, Giuseppe
Publicado no Oncotarget (2016)

Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after fir...

Por Cardone, Claudia, Martinelli, Erika, Troiani, Teresa, Sforza, Vincenzo, Avallone, Antonio, Nappi, Anna, Montesarchio, Vincenzo, Andreozzi, Francesca, Biglietto, Maria, Calabrese, Filomena, Bordonaro, Roberto, Cordio, Stefano, Bregni, Giacomo, Febbraro, Antonio, Garcia-Carbonero, Rocio, Feliu, Jaime, Cervantes, Andrés, Ciardiello, Fortunato
Publicado no ESMO Open (2019)

Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world stu...

Por Santini, Daniele, Cinieri, Saverio, Gasparro, Donatello, Bordonaro, Roberto, Guglielmini, Pamela Francesca, Chiuri, Vincenzo Emanuele, D'Angelillo, Rolando M, Ceresoli, Giovanni Luca, Fagnani, Daniele, Acquati, Mirko, Mencoboni, Manlio, Lanzetta, Gaetano, Sartori, Donata, Carlini, Paolo, Panebianco, Fabiana, Beccaglia, Patrizia, Procopio, Giuseppe
Publicado no J Bone Oncol (2020)

Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists

Por Blasi, Livio, Bordonaro, Roberto, Borsellino, Nicolò, Butera, Alfredo, Caruso, Michele, Cordio, Stefano, Liborio, Di Cristina, Ferraù, Francesco, Giuffrida, Dario, Parra, Hector Soto, Spada, Massimiliano, Tralongo, Paolo, Valenza, Roberto, Verderame, Francesco, Vitello, Stefano, Zerilli, Filippo, Piazza, Dario, Firenze, Alberto, Gebbia, Vittorio
Publicado no Ecancermedicalscience (2020)

Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: t...

Por Procopio, Giuseppe, Chiuri, Vincenzo Emanuele, Giordano, Monica, Mantini, Giovanna, Maisano, Roberto, Bordonaro, Roberto, Calvani, Nicola, Facchini, Gaetano, De Placido, Sabino, Airoldi, Mario, Sbrana, Andrea, Gasparro, Donatello, Ludovico, Giuseppe Mario, Guglielmini, Pamela, Naglieri, Emanuele, Fagnani, Daniele, Aglietta, Massimo, Schips, Luigi, Beccaglia, Patrizia, Sciarra, Alessandro, Livi, Lorenzo, Santini, Daniele
Publicado no Ther Adv Med Oncol (2020)

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy

Por Fanotto, Valentina, Uccello, Mario, Pecora, Irene, Rimassa, Lorenza, Leone, Francesco, Rosati, Gerardo, Santini, Daniele, Giampieri, Riccardo, Di Donato, Samantha, Tomasello, Gianluca, Silvestris, Nicola, Pietrantonio, Filippo, Battaglin, Francesca, Avallone, Antonio, Scartozzi, Mario, Lutrino, Eufemia Stefania, Melisi, Davide, Antonuzzo, Lorenzo, Pellegrino, Antonio, Ferrari, Laura, Bordonaro, Roberto, Vivaldi, Caterina, Gerratana, Lorenzo, Bozzarelli, Silvia, Filippi, Roberto, Bilancia, Domenico, Russano, Marco, Aprile, Giuseppe
Publicado no Oncologist (2017)

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy

Por Fanotto, Valentina, Uccello, Mario, Pecora, Irene, Rimassa, Lorenza, Leone, Francesco, Rosati, Gerardo, Santini, Daniele, Giampieri, Riccardo, Di Donato, Samantha, Tomasello, Gianluca, Silvestris, Nicola, Pietrantonio, Filippo, Battaglin, Francesca, Avallone, Antonio, Scartozzi, Mario, Lutrino, Eufemia Stefania, Melisi, Davide, Antonuzzo, Lorenzo, Pellegrino, Antonio, Ferrari, Laura, Bordonaro, Roberto, Vivaldi, Caterina, Gerratana, Lorenzo, Bozzarelli, Silvia, Filippi, Roberto, Bilancia, Domenico, Russano, Marco, Aprile, Giuseppe
Publicado no Oncologist (2018)

DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients

Por Del Re, Marzia, Cinieri, Saverio, Michelucci, Angela, Salvadori, Stefano, Loupakis, Fotios, Schirripa, Marta, Cremolini, Chiara, Crucitta, Stefania, Barbara, Cecilia, Di Leo, Angelo, Latiano, Tiziana Pia, Pietrantonio, Filippo, Di Donato, Samantha, Simi, Paolo, Passardi, Alessandro, De Braud, Filippo, Altavilla, Giuseppe, Zamagni, Claudio, Bordonaro, Roberto, Butera, Alfredo, Maiello, Evaristo, Pinto, Carmine, Falcone, Alfredo, Mazzotti, Valentina, Morganti, Riccardo, Danesi, Romano
Publicado no Pharmacogenomics J (2019)

Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting

Por Generali, Daniele, Montemurro, Filippo, Bordonaro, Roberto, Mafodda, Antonino, Romito, Sante, Michelotti, Andrea, Piovano, Pierluigi, Ionta, Maria Teresa, Bighin, Claudia, Sartori, Donata, Frassoldati, Antonio, Cazzaniga, Marina Elena, Riccardi, Ferdinando, Testore, Franco, Vici, Patrizia, Barone, Carlo Antonio, Schirone, Alessio, Piacentini, Federico, Nolè, Franco, Molino, Annamaria, Latini, Luciano, Simoncini, Edda Lucia, Roila, Fausto, Cognetti, Francesco, Nuzzo, Francesco, Foglietta, Jennifer, Minisini, Alessandro Marco, Goffredo, Francesca, Portera, Giuseppe, Ascione, Gilda, Mariani, Gabriella
Publicado no Oncologist (2017)